Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2015 Mar;100(3):e106-9.
doi: 10.3324/haematol.2014.116087. Epub 2014 Dec 5.

Serum survivin and vascular endothelial growth factor in extranodal NK/T-cell lymphoma, nasal type: implications for a potential new prognostic indicator

Seok Jin Kim  1 , Mineui Hong  2 , In-Gu Do  2 , Seung Ho Lee  3 , Kyung Ju Ryu  4 , Hae Yong Yoo  5 , Jung Yong Hong  6 , Young Hyeh Ko  2 , Won Seog Kim  7
Affiliations
Clinical Trial

Serum survivin and vascular endothelial growth factor in extranodal NK/T-cell lymphoma, nasal type: implications for a potential new prognostic indicator

Seok Jin Kim et al. Haematologica. 2015 Mar.
No abstract available

Keywords: extranodal NK/T-cell lymphoma; prognosis; serum; survivin; vascular endothelial growth factor.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
(A) Summary of study design and patient selection. (B) Serum levels of platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), IL-6 and surviving. (C) High VEGF (pink squares) showed a significant association with progression-free survival (PFS) events (68%, 19 of 28) compared to low VEGF (empty squares, 44%, 18 of 41; P=0.05). Positive survivin (green squares) showed a high rate of failure (89%, 16 of 18) than negative survivin (41%, 21 of 51; P<0.001). Positive IL-6 (purple squares) showed a marginal significance (70%, 16 of 23; P=0.06) and high platelet-derived growth factor (PDGF) (blue squares) was not related with the occurrence of a PFS event (57%, 20 of 35).
Figure 2.
Figure 2.
(A) Patients with high serum vascular endothelial growth factor (VEGF) concentration had better overall survival compared with patients with low VEGF. Serum IL-6-positive and serum survivin-positive patients had worse overall survival compared with patients who were negative for IL-6 and survivin. (B) Serum survivin-positive patients showed a higher proportion of Epstein-Barr virus (EBV) DNA elevation (78%, 14 of 18) and stage IV (54%, 13 of 24) whereas high VEGF did not show a significant association with EBV DNA elevation and stage. (C) Hematoxylin–eosin staining of a representative extranodal natural killer/T-cell lymphoma (ENKTL) sample; EBV-encoded small RNA in situ hybridization; strong nuclear survivin expression in lymphoma cells (X400). (D) NK-92MI cells treated with VEGF exhibited greater cell proliferation (P<0.01) compared with cells cultured without VEGF. Each condition with five replicates was repeated three times, and the data are expressed as mean±standard deviation. OD: optical density. (E) Treatment of VEGF-A (1 ng/mL) increased the invasiveness (*P<0.01). The values are from 3 independent experiments, and the data are expressed as mean±standard deviation. (F) Treatment of VEGF-A increased AKT phosphorylation (p-AKT).
See this image and copyright information in PMC

References

    1. William BM, Armitage JO. International analysis of the frequency and outcomes of NK/T-cell lymphomas. Best Pract Res Clin Haematol. 2013;26(1):23–32. - PubMed
    1. Huang Y, de Reynies A, de Leval L, et al. Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type. Blood. 2010;115(6):1226–1237. - PMC - PubMed
    1. Huang Y, de Leval L, Gaulard P. Molecular underpinning of extranodal NK/T-cell lymphoma. Best Pract Res Clin Haematol. 2013;26(1):57–74. - PubMed
    1. Kim HS, Kim KH, Kim KH, et al. Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer/T-cell lymphoma. Leuk Lymphoma. 2009;50(5):757–763. - PubMed
    1. Germi R, Lupo J, Semenova T, et al. Comparison of commercial extraction systems and PCR assays for quantification of Epstein-Barr virus DNA load in whole blood. J Clin Microbiol. 2012;50(4):1384–1389. - PMC - PubMed

MeSH terms

Associated data